The Investment Advantages of Berkshire Hathaway
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 18 hours ago
0mins
Should l Buy GOOGL?
Source: Fool
- Diversified Portfolio: Berkshire Hathaway boasts over 60 subsidiaries across various sectors, including insurance, energy, construction, manufacturing, railroads, and dining, making its diversification comparable to some exchange-traded funds (ETFs).
- Indirect Stock Holdings: By owning shares of Berkshire, investors can indirectly hold positions in five other stocks, including Apple, Alphabet (Google's parent), Amazon, Chevron, and Mastercard, thereby achieving broader market exposure.
- Strong Long-term Prospects: Berkshire's portfolio also includes companies like American Express, Coca-Cola, and Visa, which have solid long-term growth potential, enhancing its investment appeal.
- Management Stability: Although Warren Buffett is no longer CEO, he remains confident in the company's future and believes that under Greg Abel's leadership, Berkshire's prospects will improve, demonstrating the stability of its governance and potential for continued growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GOOGL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GOOGL
Wall Street analysts forecast GOOGL stock price to rise
33 Analyst Rating
26 Buy
7 Hold
0 Sell
Strong Buy
Current: 309.000
Low
305.00
Averages
374.25
High
400.00
Current: 309.000
Low
305.00
Averages
374.25
High
400.00
About GOOGL
Alphabet Inc. is a holding company. The Company's segments include Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment includes infrastructure and platform services, collaboration tools, and other services for enterprise customers. Its Other Bets segment is engaged in the sale of healthcare-related services and Internet services. Its Google Cloud provides enterprise-ready cloud services, including Google Cloud Platform and Google Workspace. Google Cloud Platform provides access to solutions such as artificial intelligence (AI) offerings, including its AI infrastructure, Vertex AI platform, and Gemini for Google Cloud; cybersecurity, and data and analytics. Google Workspace includes cloud-based communication and collaboration tools for enterprises, such as Calendar, Gmail, Docs, Drive, and Meet.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alphabet's Retreat: An Opportunity for Long-Term Investors?
Alphabet's Performance: Alphabet (NASDAQ: GOOGL) has shown strong performance over the past year, climbing over 68% due to its leadership in AI, consistent earnings beats, and growth in cloud and advertising sectors, despite a recent slip into negative territory.
Earnings Report Highlights: The latest quarterly results exceeded earnings and revenue expectations, with earnings per share at $2.82 and revenue reaching $113.83 billion, marking a 17% year-over-year growth, particularly driven by a surge in cloud revenue.
Investment Concerns: Despite strong fundamentals, Alphabet's stock has faced recent pullbacks, raising questions among investors about potential fatigue or long-term buying opportunities, especially in light of expected capital expenditures between $175 billion and $185 billion for 2026.
AI and Market Position: Alphabet continues to expand its AI capabilities and maintain a moderate buy rating, with analysts suggesting that the current stock price offers a significant upside, reflecting the company's ambition and resilience in a challenging tech environment.
See More
AI Competition Intensifies as ChatGPT Faces Challenges
- User Growth Comparison: Google's Gemini app has reached 750 million monthly active users, increasing by 100 million from the previous quarter, closely approaching ChatGPT's estimated 800 million users, indicating a significant threat to ChatGPT's market share.
- Revenue Driver: Although Google does not directly attribute revenue to Gemini, its strong growth in cloud and services units suggests that Gemini is a key contributor to the company's overall performance, with annual revenue surpassing $400 billion for the first time in 2025, marking a 15% year-over-year increase.
- Competitive Landscape: OpenAI faces fierce competition from major tech players like Google, as Gemini's rapid rise could erode ChatGPT's market share, forcing OpenAI to increase its infrastructure investments to maintain competitiveness.
- Funding Needs: To address competition and infrastructure commitments, OpenAI is reportedly close to completing a funding round of up to $100 billion, highlighting the financial pressures it faces in sustaining innovation and market expansion.
See More
Analysis of Nvidia's Recent Stock Underperformance
- Strong Financial Performance: Despite Nvidia's (NVDA) 2% year-to-date stock decline, its latest earnings report indicates accelerating revenue growth in Q3, with strong guidance for Q4, suggesting robust market demand in the AI sector that could drive future sales growth.
- Giant Investment Plans: Tech giants like Amazon, Alphabet, and Microsoft have announced massive AI investments, with Amazon planning to spend around $200 billion despite only $11.2 billion in trailing twelve-month free cash flow, raising concerns about sustainability while potentially boosting Nvidia's sales in the short term.
- In-House Chip Programs Rising: Amazon's Trainium2 AI chip business is generating over $10 billion in annual revenue and is fully subscribed, indicating that competitors are rapidly developing their own chip solutions, which could erode Nvidia's market share, especially as price competition intensifies.
- Valuation Pressure: Nvidia's current P/E ratio stands at 45, with a forward P/E of 24; while the company is experiencing rapid earnings growth, any slowdown in AI chip demand or the emergence of lower-cost alternatives from competitors could pressure Nvidia's pricing power and margins, leading to further stock price declines.
See More
Anthropic Refuses Military AI Use, Heightening Tensions
- Refusal of Military Cooperation: Anthropic's refusal to allow the U.S. military to use its AI for surveillance and battlefield operations has escalated tensions, potentially jeopardizing its relationship with the U.S. government.
- Investor Focus: As a major investor in Anthropic with over $8 billion invested, Amazon could face negative stock price impacts if the military terminates its contract with Anthropic, particularly amid a broader selloff in technology stocks.
- Contractual Risks: The Pentagon is considering designating Anthropic as a 'supply chain risk,' meaning any company doing business with the U.S. military would need to sever ties with Anthropic, which could severely limit its future business opportunities.
- Market Sentiment Shift: Despite Amazon's stock dropping over 18% in the past eight trading sessions, retail sentiment on Stocktwits remains 'bullish,' indicating investor confidence in Amazon's future, particularly due to the strong performance of its AWS services.
See More
Broadcom Could Emerge as New AI Giant
- Significant AI Growth: Broadcom's AI semiconductor revenue surged 74% year-over-year in the latest quarter, with projections indicating it will reach $8.2 billion in Q1, showcasing strong market demand and growth potential.
- Record Backlog: The backlog for Broadcom's AI switches has exceeded $10 billion, reflecting the company's critical role in AI data center buildouts and strong market confidence.
- Product Differentiation: Broadcom has launched the industry's first Wi-Fi 8 access point and switch system, aimed at enhancing security and speed for enterprises using AI, thereby further solidifying its market position.
- Competitive Strategy: Broadcom's custom XPUs complement Nvidia and AMD's general-purpose GPUs, allowing the company to grow rapidly in specific niches while avoiding the pressures of direct competition.
See More
Three Stocks Set to Outperform the Market in 2026
- Alphabet Cloud Growth: Alphabet's cloud business had an annual revenue run rate of approximately $70 billion at the end of 2025, with a backlog growth exceeding 100% year-over-year to $240 billion in Q4, which is expected to significantly enhance the company's profitability in 2026 and solidify its leadership in the AI sector.
- BeOne Drug Development Progress: BeOne Medicines plans to announce Phase 3 study results for Brukinsa in combination with rituximab in the first half of 2026, and is expected to gain U.S. regulatory approval for sonrotoclax, further enhancing its competitiveness in the blood cancer treatment market.
- Rhythm Drug Approval Outlook: Rhythm Pharmaceuticals' Imcivree is anticipated to receive FDA approval for treating acquired hypothalamic obesity by March 20, 2026, which would significantly expand its market potential as this condition affects more patients than the combined total of its three existing indications.
- Multiple Clinical Trial Data Releases: Rhythm also plans to report top-line data from a Phase 3 study evaluating Imcivree in four other genetic diseases in Q1 2026 and disclose results from an exploratory Phase 2 study on Prader-Willi syndrome in the first half of the year, further boosting investor confidence.
See More
Alphabet's Retreat: An Opportunity for Long-Term Investors?
Alphabet's Performance: Alphabet (NASDAQ: GOOGL) has shown strong performance over the past year, climbing over 68% due to its leadership in AI, consistent earnings beats, and growth in cloud and advertising sectors, despite a recent slip into negative territory.
Earnings Report Highlights: The latest quarterly results exceeded earnings and revenue expectations, with earnings per share at $2.82 and revenue reaching $113.83 billion, marking a 17% year-over-year growth, particularly driven by a surge in cloud revenue.
Investment Concerns: Despite strong fundamentals, Alphabet's stock has faced recent pullbacks, raising questions among investors about potential fatigue or long-term buying opportunities, especially in light of expected capital expenditures between $175 billion and $185 billion for 2026.
AI and Market Position: Alphabet continues to expand its AI capabilities and maintain a moderate buy rating, with analysts suggesting that the current stock price offers a significant upside, reflecting the company's ambition and resilience in a challenging tech environment.
See More
AI Competition Intensifies as ChatGPT Faces Challenges
- User Growth Comparison: Google's Gemini app has reached 750 million monthly active users, increasing by 100 million from the previous quarter, closely approaching ChatGPT's estimated 800 million users, indicating a significant threat to ChatGPT's market share.
- Revenue Driver: Although Google does not directly attribute revenue to Gemini, its strong growth in cloud and services units suggests that Gemini is a key contributor to the company's overall performance, with annual revenue surpassing $400 billion for the first time in 2025, marking a 15% year-over-year increase.
- Competitive Landscape: OpenAI faces fierce competition from major tech players like Google, as Gemini's rapid rise could erode ChatGPT's market share, forcing OpenAI to increase its infrastructure investments to maintain competitiveness.
- Funding Needs: To address competition and infrastructure commitments, OpenAI is reportedly close to completing a funding round of up to $100 billion, highlighting the financial pressures it faces in sustaining innovation and market expansion.
See More
Analysis of Nvidia's Recent Stock Underperformance
- Strong Financial Performance: Despite Nvidia's (NVDA) 2% year-to-date stock decline, its latest earnings report indicates accelerating revenue growth in Q3, with strong guidance for Q4, suggesting robust market demand in the AI sector that could drive future sales growth.
- Giant Investment Plans: Tech giants like Amazon, Alphabet, and Microsoft have announced massive AI investments, with Amazon planning to spend around $200 billion despite only $11.2 billion in trailing twelve-month free cash flow, raising concerns about sustainability while potentially boosting Nvidia's sales in the short term.
- In-House Chip Programs Rising: Amazon's Trainium2 AI chip business is generating over $10 billion in annual revenue and is fully subscribed, indicating that competitors are rapidly developing their own chip solutions, which could erode Nvidia's market share, especially as price competition intensifies.
- Valuation Pressure: Nvidia's current P/E ratio stands at 45, with a forward P/E of 24; while the company is experiencing rapid earnings growth, any slowdown in AI chip demand or the emergence of lower-cost alternatives from competitors could pressure Nvidia's pricing power and margins, leading to further stock price declines.
See More
Anthropic Refuses Military AI Use, Heightening Tensions
- Refusal of Military Cooperation: Anthropic's refusal to allow the U.S. military to use its AI for surveillance and battlefield operations has escalated tensions, potentially jeopardizing its relationship with the U.S. government.
- Investor Focus: As a major investor in Anthropic with over $8 billion invested, Amazon could face negative stock price impacts if the military terminates its contract with Anthropic, particularly amid a broader selloff in technology stocks.
- Contractual Risks: The Pentagon is considering designating Anthropic as a 'supply chain risk,' meaning any company doing business with the U.S. military would need to sever ties with Anthropic, which could severely limit its future business opportunities.
- Market Sentiment Shift: Despite Amazon's stock dropping over 18% in the past eight trading sessions, retail sentiment on Stocktwits remains 'bullish,' indicating investor confidence in Amazon's future, particularly due to the strong performance of its AWS services.
See More
Broadcom Could Emerge as New AI Giant
- Significant AI Growth: Broadcom's AI semiconductor revenue surged 74% year-over-year in the latest quarter, with projections indicating it will reach $8.2 billion in Q1, showcasing strong market demand and growth potential.
- Record Backlog: The backlog for Broadcom's AI switches has exceeded $10 billion, reflecting the company's critical role in AI data center buildouts and strong market confidence.
- Product Differentiation: Broadcom has launched the industry's first Wi-Fi 8 access point and switch system, aimed at enhancing security and speed for enterprises using AI, thereby further solidifying its market position.
- Competitive Strategy: Broadcom's custom XPUs complement Nvidia and AMD's general-purpose GPUs, allowing the company to grow rapidly in specific niches while avoiding the pressures of direct competition.
See More
Three Stocks Set to Outperform the Market in 2026
- Alphabet Cloud Growth: Alphabet's cloud business had an annual revenue run rate of approximately $70 billion at the end of 2025, with a backlog growth exceeding 100% year-over-year to $240 billion in Q4, which is expected to significantly enhance the company's profitability in 2026 and solidify its leadership in the AI sector.
- BeOne Drug Development Progress: BeOne Medicines plans to announce Phase 3 study results for Brukinsa in combination with rituximab in the first half of 2026, and is expected to gain U.S. regulatory approval for sonrotoclax, further enhancing its competitiveness in the blood cancer treatment market.
- Rhythm Drug Approval Outlook: Rhythm Pharmaceuticals' Imcivree is anticipated to receive FDA approval for treating acquired hypothalamic obesity by March 20, 2026, which would significantly expand its market potential as this condition affects more patients than the combined total of its three existing indications.
- Multiple Clinical Trial Data Releases: Rhythm also plans to report top-line data from a Phase 3 study evaluating Imcivree in four other genetic diseases in Q1 2026 and disclose results from an exploratory Phase 2 study on Prader-Willi syndrome in the first half of the year, further boosting investor confidence.
See More
